30 results on '"Gomila I"'
Search Results
2. La política exterior russa durant el període 2012-2018 : entre el nacionalisme, la seguretat i el realisme
- Author
-
Gomila i Servera, Antoni, Universitat Autònoma de Barcelona. Facultat de Ciències Polítiques i de Sociologia, and Serra Massansalvador, Francesc
- Subjects
Dilema de seguridad ,Política exterior ,Realismo ,Nacionalismo ruso ,Realism ,Realisme ,Securiy dilemma ,Russian nationalism ,Foreign policy ,Nacionalisme rus ,Vladimir Putin ,Dilema de seguretat - Abstract
Amb la tornada de Vladimir Putin a la Presidència de la Federació Rússia al 2012, s'iniciava el ser tercer mandat presidencial. Aquest mandat ha estat marcat per una política nacional i exterior definida i amb uns objectius clars: retornar Rússia al paper de potència rellevant a nivell mundial, mantenir la unitat nacional del país, i garantir les demandes de seguretat envers Occident. Per a portar-ho a terme, Rússia ha apostat per una política exterior marcada pel realisme ofensiu i pel nacionalisme rus. El treball intentarà explicar com aquests dos conceptes són indestriables l'un de l'altre a l'hora de poder garantir les demandes sobre seguretat, les quals engloben la no expansió de la OTAN, el disseny d'una arquitectura de seguretat europea i el respecte mutu sobre la sobirania dels estats entre Rússia i Occident. With the return of Vladimir Putin to the presidency of the Russian Federation in 2012, his third presidential term began. This mandate has been marked by a definite national and foreign policy with clear objectives: to return Russia to the role of a relevant world power, to maintain the country's national unity, and to guarantee security demands towards the West. To do so, Russia has opted for a foreign policy marked by offesnsive realism and Russian nationalism. The paper will try to explain how these two concepts are inseparable from each other when it comes to being able to guarantee security demands, which include the non-expansion of NATO, the design of a European security architecture and the mutual respect on the sovereignty of the states between Russia and the West.
- Published
- 2021
3. Clinical features and risk factors associated with prenatal exposure to drugs of abuse [Características clínicas y factores de riesgo asociados a la exposición prenatal a drogas de abuso]
- Author
-
Roca, A., Jarque, P., Gomila, I., Marchei, E., Tittarelli, R., Elorza, M. A., Sanchis, P., and Barcelo, B.
- Subjects
biomarkers ,meconium ,neonatal intensive care unit ,prenatal exposure - Published
- 2021
4. Post-mortem toxicology in the diagnosis of sudden death in young and middle-aged victims.
- Author
-
RIPOLL, T., GARCÍA, A. B., GOMILA, I., HEINE, D., PONCELA, J. L., SÁNCHEZ, N., PÉREZ, C., GARCÍA, E., HERNÁNDEZ, E., BARCELÓ, A., BUSARDO, F. P., and BARCELÓ, B.
- Abstract
OBJECTIVE: We aimed to investigate the impact of the toxicological results found in cases of sudden death (SD) and to correlate the clinical, autopsy and genetic findings with the toxicology results. MATERIALS AND METHODS: Consecutive SD in people aged between 16 and 50 years with medico-legal autopsies and toxicology studies were included over a 3-year period. The comparison between the toxicological data and demographic characteristics, clinical circumstances, autopsy, and genetic results were taken into account. RESULTS: 101 cases were finally included. They were predominately males (84%) and the mean age was 39.8 years. 52 (51.5%) cases had positive toxicological findings and in 25 cases (24.8%), toxic compounds were considered the first cause of death. Ethanol was the most frequently identified agent (69%), following by licit drugs (56%) and drugs of abuse (39%). Cases with positive toxicology were younger than those with negative results (37.9±9.1 vs. 41.9±7.8; p=0.02). Patients with more than 3 comorbidities showed an association with positive toxicological results (n=14 vs. n=3; p=0.017). The genetic study was performed in 70 (69.3%) SD cases. We identified pathogenic or likely pathogenic variants in 17.1% cases and uncertain significance variants in 42.8% cases. 58% of these variants were probably related to the cause of death. CONCLUSIONS: A large fraction of SD victims had positive toxicological findings and a quarter of deaths were directly caused by toxic substances. The identification of the factors that trigger SD provides a good approach to contribute in avoiding future episodes. [ABSTRACT FROM AUTHOR]
- Published
- 2019
5. Association of Low Protein-to-Carbohydrate Energy Ratio with Cognitive Impairment in Elderly Type 2 Diabetes Patients.
- Author
-
Pujol A, Sanchis P, Tamayo MI, Godoy S, Andrés P, Speranskaya A, Espino A, Estremera A, Rigo E, Amengual GJ, Rodríguez M, Ribes JL, Gomila I, Grases F, González-Freire M, and Masmiquel L
- Subjects
- Humans, Female, Male, Aged, Cross-Sectional Studies, Energy Intake, Risk Factors, Cognition, Diet, Protein-Restricted, Aged, 80 and over, Diabetes Mellitus, Type 2 complications, Cognitive Dysfunction etiology, Dietary Carbohydrates administration & dosage, Dietary Proteins administration & dosage
- Abstract
Background/objectives: The relationship between macronutrient intake and cognitive decline in older adults with type 2 diabetes mellitus (T2DM) remains underexplored., Methods: This cross-sectional study aimed to evaluate the association between the protein-to-carbohydrate energy ratio (%E:P) and cognitive impairment among 192 elderly T2DM patients. Cognitive function was assessed using the Montreal Cognitive Assessment (MoCA) and the Self-Administered Gerocognitive Exam (SAGE), while dietary intake data, including (%E:P), was gathered using a validated semi-quantitative food frequency questionnaire., Results: Participants had a mean age of 71 ± 6 years, 46.4% were female, and the median BMI was 30 ± 4 kg/m
2 . After adjusting for confounding variables, patients in the highest (%E:P) tertile showed significantly higher MoCA and SAGE scores compared to those in the lowest tertile ( p < 0.005). We identified an optimal (%E:P) threshold of 0.375 for predicting cognitive impairment, with a sensitivity of 53% and specificity of 64%., Conclusions: These findings suggest that a lower (%E:P) ratio may be a risk factor for cognitive impairment in elderly T2DM patients. Monitoring this ratio may serve as an early detection tool for cognitive deterioration. Moreover, current protein intake recommendations for older adults with T2DM may be insufficient to prevent cognitive impairment. Further research is needed to establish optimal dietary guidelines for this population., Competing Interests: The authors declare no conflicts of interest.- Published
- 2024
- Full Text
- View/download PDF
6. Metabolic-Associated Fatty Liver Disease and Cognitive Performance in Type 2 Diabetes: Basal Data from the Phytate, Neurodegeneration and Diabetes (PHYND) Study.
- Author
-
Pujol A, Sanchis P, Tamayo MI, Godoy S, Calvó P, Olmos A, Andrés P, Speranskaya A, Espino A, Estremera A, Rigo E, Amengual GJ, Rodríguez M, Ribes JL, Gomila I, Grases F, González-Freire M, and Masmiquel L
- Abstract
The effect of liver fibrosis on mild cognitive impairment (MCI) and dementia risk in type 2 diabetes mellitus (T2DM) patients is unclear. Therefore, we performed a prospective cross-sectional study on 219 patients with T2DM and older than 60 years to evaluate the association between liver fibrosis, liver steatosis, and cognitive impairment. The Montreal Cognitive Assessment (MoCA) was used to screen for MCI or dementia. Liver fibrosis was estimated using the non-invasive Fibrosis-4 (FIB-4) score, and liver steatosis was assessed with the hepatic steatosis index. The mean age was 71 ± 6 years, 47% were women and according to MoCA cut-off values, 53.88% had MCI and 16.43% had dementia. A moderate or high risk of advanced fibrosis was significantly higher in patients with MCI or dementia compared to those with normal cognition ( p < 0.001). After adjusting for confounders, a FIB-4 score greater than 1.54 was associated with MCI or dementia ( p = 0.039). Multivariate analysis identified age over 70.5 years, antiplatelet medication use, and a FIB-4 score above 1.54 as the most relevant risk factors. Liver fibrosis, but not liver steatosis, is associated with MCI or dementia in older T2DM patients, suggesting that FIB-4 score might be a simple biomarker for the detection of cognitive impairment.
- Published
- 2024
- Full Text
- View/download PDF
7. Evaluation of three-year neurodevelopmental outcomes in infants prenatally exposed to substance use.
- Author
-
Jarque P, Carmona M, Roca A, Barcelo B, Pichini S, Elorza MÁ, Sanchis P, Rendal Y, and Gomila I
- Subjects
- Humans, Female, Male, Pregnancy, Case-Control Studies, Prospective Studies, Child, Preschool, Child Development drug effects, Child Development physiology, Infant, Adult, Developmental Disabilities chemically induced, Neurodevelopmental Disorders chemically induced, Motor Skills drug effects, Motor Skills physiology, Prenatal Exposure Delayed Effects, Substance-Related Disorders complications
- Abstract
Introduction: Prenatal exposure to substance use is associated with long-term deficits in the neurodevelopment of children. The objective was to investigate the association between cognitive, motor, and language neurodevelopment at three years of age in infants prenatally exposed to substance use., Material and Methods: A prospective matched case-control study was conducted. Biomarkers of fetal exposure were measured in meconium samples. The Bayley Scales of Infant and Toddler Development (BSID-III) were used to calculate neurodevelopment scores., Results: 32 non-exposed and 32 exposed infants were evaluated, of which 16 were exposed to cannabis, 8 to ethanol, 2 to cocaine and 6 to more than one substance. Normal BSID-III scores ≥85 in all domains, were detected in 23 exposed infants to any substance and 29 infants non-exposed. Neurodevelopmental delay was detected in the language domain, specifically in male infants exposed to cannabis. Two infants exposed to cannabis had a severe developmental delay (score<70). Infants exposed to any substance obtained significantly lower total scores than control infants in all domains. Infants exposed to cannabis obtained significantly lower composite scores in the cognitive and motor domains. Infants exposed to more than one substance had lower scores in motor skills. By gender, only males exposed obtained significantly lower composite scores than non-exposed males in the cognitive domain., Conclusions: The most common and severe neurodevelopmental delay at 36 months was detected in the domain of language in male infants prenatally exposed to cannabis. Neurodevelopmental disorders detected can enable an early intervention and plan therapeutic strategies., Competing Interests: Declaration of Competing Interest The authors declare no conflict of interest., (Copyright © 2024 Elsevier B.V. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
8. Oral phytate supplementation on the progression of mild cognitive impairment, brain iron deposition and diabetic retinopathy in patients with type 2 diabetes: a concept paper for a randomized double blind placebo controlled trial (the PHYND trial).
- Author
-
Pujol A, Sanchis P, Tamayo MI, Nicolau J, Grases F, Espino A, Estremera A, Rigo E, Amengual GJ, Rodríguez M, Ribes JL, Gomila I, Simó-Servat O, and Masmiquel L
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Administration, Oral, Double-Blind Method, Randomized Controlled Trials as Topic, Brain metabolism, Brain drug effects, Cognitive Dysfunction metabolism, Cognitive Dysfunction etiology, Cognitive Dysfunction prevention & control, Diabetes Mellitus, Type 2 metabolism, Diabetes Mellitus, Type 2 complications, Diabetic Retinopathy metabolism, Diabetic Retinopathy drug therapy, Dietary Supplements, Disease Progression, Iron metabolism, Iron administration & dosage, Phytic Acid administration & dosage
- Abstract
Type 2 diabetes mellitus has a worldwide prevalence of 10.5% in the adult population (20-79 years), and by 2045, the prevalence is expected to keep rising to one in eight adults living with diabetes. Mild cognitive impairment has a global prevalence of 19.7% in adults aged 50 years. Both conditions have shown a concerning increase in prevalence rates over the past 10 years, highlighting a growing public health challenge. Future forecasts indicate that the prevalence of dementia (no estimations done for individuals with mild cognitive impairment) is expected to nearly triple by 2050. Type 2 diabetes mellitus is a risk factor for the development of cognitive impairment, and such impairment increase the likelihood of poor glycemic/metabolic control. High phytate intake has been shown to be a protective factor against the development of cognitive impairment in observational studies. Diary phytate intake might reduce the micro- and macrovascular complications of patients with type 2 diabetes mellitus through different mechanisms. We describe the protocol of the first trial (the PHYND trial) that evaluate the effect of daily phytate supplementation over 56 weeks with a two-arm double-blind placebo-controlled study on the progression of mild cognitive impairment, cerebral iron deposition, and retinal involvement in patients with type 2 diabetes mellitus. Our hypothesis proposes that phytate, by inhibiting advanced glycation end product formation and chelating transition metals, will improve cognitive function and attenuate the progression from Mild Cognitive Impairment to dementia in individuals with type 2 diabetes mellitus and mild cognitive impairment. Additionally, we predict that phytate will reduce iron accumulation in the central nervous system, mitigate neurodegenerative changes in both the central nervous system and retina, and induce alterations in biochemical markers associated with neurodegeneration., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2024 Pujol, Sanchis, Tamayo, Nicolau, Grases, Espino, Estremera, Rigo, Amengual, Rodríguez, Ribes, Gomila, Simó-Servat and Masmiquel.)
- Published
- 2024
- Full Text
- View/download PDF
9. High-sensitivity troponin I elevation and hyperamylasemia in a pediatric case with tramadol and morphine overdose.
- Author
-
González Lago S, Pérez García MJ, Gomila I, Puiguriguer J, and Barceló B
- Subjects
- Humans, Child, Troponin I, Analgesics, Opioid adverse effects, Morphine Derivatives, Tramadol adverse effects, Hyperamylasemia, Drug-Related Side Effects and Adverse Reactions
- Published
- 2022
- Full Text
- View/download PDF
10. Cardiac Arrest Following Unsuspected Self-Poisoning With Doxylamine.
- Author
-
Gomila I, Socias A, Socias L, Gutierrez L, Ripoll T, Alarcón FJ, García AB, and Barceló B
- Subjects
- Humans, Pyridines, Doxylamine, Heart Arrest chemically induced
- Abstract
Competing Interests: The authors declare no conflict of interest.
- Published
- 2022
- Full Text
- View/download PDF
11. Clinical features and risk factors associated with prenatal exposure to drugs of abuse.
- Author
-
Roca A, Jarque P, Gomila I, Marchei E, Tittarelli R, Elorza MÁ, Sanchís P, and Barceló B
- Subjects
- Aged, Humans, Infant, Newborn, Pregnancy, Meconium, Risk Factors, Female, Cannabis, Pharmaceutical Preparations, Prenatal Exposure Delayed Effects epidemiology
- Abstract
Introduction: Early identification of neonates exposed to drugs of abuse during pregnancy allows a more precise clinical management., Objectives: To describe the clinical characteristics and to identify risk factors associated with the early detection of neonates exposed to drugs of abuse in a Neonatal Intermediate and Intensive Care Unit., Methods: Prospective observational study of neonates with and without clinical suspicion of prenatal exposure to drugs of abuse. Meconium was analyzed using standard chromatographic techniques. Univariate and multivariate statistical analyzes were performed., Results: 372 neonates were included. Exposure to drugs of abuse was detected in 49 (13.2%) cases: in 41 (83.7%) one drug and in 8 (16.3%) more than one. Somatometry at birth revealed: a) lower length percentile in those exposed to some drug, more than one and cannabis; b) lower weight percentile in those exposed to cannabis and of these compared to those exposed to alcohol. In neonates older than 34 pregnancy weeks (PW): a) lower length percentile in those exposed to any substance; b) lower percentile of length and weight in exposed to more than one. The most clinically relevant independent risk factors useful to detect cases of prenatal exposure to drugs of abuse were (Odds ratio (95% CI)): reason for admission other than prematurity (5.52 (2.55-1.93)), length percentile less than 33 (1.95 (1.05-3.60) and 2.14 (1.04-3.40) in older than 34 PW) and social dystocia/uncontrolled pregnancy in older than 34 PW (4.47 (1.03-19.29))., Conclusions: There are somatometric alterations and risk factors that can help in the early detection of neonates exposed to drugs of abuse. The somatometric alterations identified can be useful to extend the differential diagnosis of these alterations and to study their causes., (Copyright © 2021 Asociación Española de Pediatría. Published by Elsevier España, S.L.U. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
12. Diminished Consciousness in a Woman Following an Unsuspected Scopolamine Overdose.
- Author
-
Barceló B, Gomila I, de-Castro-Ríos A, Perez-Barcena J, Jimenez C, Lendoiro E, and Elorza MÁ
- Subjects
- Female, Humans, Scopolamine, Consciousness, Drug Overdose diagnosis
- Abstract
Scopolamine is used clinically, but it is also used as a recreational drug and as an incapacitating drug, in sexual crimes and robberies. In this paper, the authors report the case of a woman with a diminished consciousness following an unsuspected overdose with scopolamine and review published articles on scopolamine poisoning that included concentrations in biological samples. Scopolamine was identified in the patient's serum and urine samples collected 1 h post-admission to intensive care unit at concentrations of 8.4 ng/mL and 62,560 ng/mL (169,539 ng/mg creatinine), respectively. In non-fatal cases, the median [interquartile range] of serum scopolamine levels was 1.9 [2.1] ng/mL. The serum concentration found in our case would explain the abrupt clinical presentation suffered by the patient. Scopolamine in urine could be detected up to 48 h after admission. This report illustrates that broad toxicology screening, including scopolamine, should be considered when patients with diminished consciousness are attended after ruling out infection or cerebrovascular disease. This can play an important role in identifying this potentially life-threatening etiology., (© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
13. Role of Neonatal Biomarkers of Exposure to Psychoactive Substances to Identify Maternal Socio-Demographic Determinants.
- Author
-
Jarque P, Roca A, Gomila I, Marchei E, Tittarelli R, Elorza MÁ, Sanchís P, and Barceló B
- Abstract
Background: The accurate assessment of fetal exposure to psychoactive substances provides the basis for appropriate clinical care of neonates. The objective of this study was to identify maternal socio-demographic profiles and risk factors for prenatal exposure to drugs of abuse by measuring biomarkers in neonatal matrices., Methods: A prospective, observational cohort study was completed. Biomarkers of fetal exposure were measured in meconium samples. The mothers were interviewed using a questionnaire. Univariate and multivariate logistic regression analyses were performed., Results: A total of 372 mothers were included, 49 (13.2%) testing positive for psychoactive substances use: 24 (49.0%) for cannabis, 11 (22.5%) for ethyl glucuronide, six (12.2%) for cocaine, and in eight (16.3%) more than one psychoactive substance. Mothers who consumed any psychoactive substance (29.7 ± 6.6 years) or cannabis (27.0 ± 5.7 years) were younger than non-users (32.8 ± 6.2 years, p < 0.05). Cocaine (50.0% vs. 96.9%, p < 0.05) and polydrug users (37.5% vs. 96.9%, p < 0.05) showed a lower levels of pregnancy care. Previous abortions were associated with the use of two or more psychoactive substances (87.5% vs. 37.8%, p < 0.05). Single-mother families (14.3% vs. 2.5%, p < 0.05) and mothers with primary level education (75.5% vs. 55.1%, p < 0.05) presented a higher consumption of psychoactive substances. Independent risk factors that are associated with prenatal exposure include: maternal age < 24 years (odds ratio: 2.56; 95% CI: 1.12-5.87), lack of pregnancy care (odds ratio: 7.27; 95%CI: 2.51-21.02), single-mother families (odds ratio: 4.98; 95%CI: 1.37-8.13), and active tobacco smoking (odds ratio: 8.13; 95%CI: 4.03-16.43)., Conclusions: These results will allow us to develop several risk-based drug screening approaches to improve the early detection of exposed neonates.
- Published
- 2021
- Full Text
- View/download PDF
14. [Clinical features and risk factors associated with prenatal exposure to drugs of abuse].
- Author
-
Roca A, Jarque P, Gomila I, Marchei E, Tittarelli R, Elorza MÁ, Sanchís P, and Barceló B
- Abstract
Introduction: Early identification of neonates exposed to drugs of abuse during pregnancy allows a more precise clinical management., Objectives: To describe the clinical characteristics and to identify risk factors associated with the early detection of neonates exposed to drugs of abuse in a Neonatal Intermediate and Intensive Care Unit., Methods: Prospective observational study of neonates with and without clinical suspicion of prenatal exposure to drugs of abuse. Meconium was analyzed using standard chromatographic techniques. Univariate and multivariate statistical analyzes were performed., Results: 372 neonates were included. Exposure to drugs of abuse was detected in 49 (13.2%) cases: in 41 (83.7%) one drug and in 8 (16.3%) more than one. Somatometry at birth revealed: a) lower length percentile in those exposed to some drug, more than one and cannabis; b) lower weight percentile in those exposed to cannabis and of these compared to those exposed to alcohol. In neonates older than 34 pregnancy weeks (PW): a) lower length percentile in those exposed to any substance; b) lower percentile of length and weight in exposed to more than one. The most clinically relevant independent risk factors useful to detect cases of prenatal exposure to drugs of abuse were (Odds ratio (95% CI)): reason for admission other than prematurity (5.52 (2.55-1.93)), length percentile less than 33 (1.95 (1.05-3.60) and 2.14 (1.04-3.40) in older than 34 PW) and social dystocia/uncontrolled pregnancy in older than 34 PW (4.47 (1.03-19.29))., Conclusions: There are somatometric alterations and risk factors that can help in the early detection of neonates exposed to drugs of abuse. The somatometric alterations identified can be useful to extend the differential diagnosis of these alterations and to study their causes., (Copyright © 2020. Publicado por Elsevier España, S.L.U.)
- Published
- 2020
- Full Text
- View/download PDF
15. Detectability of Dissociative Psychoactive Substances in Urine by Five Commercial Phencyclidine Immunoassays.
- Author
-
Gomila I, Leciñena MÁ, Elorza MÁ, Pastor Y, Sahuquillo L, Servera M, Puiguriguer J, and Barcelo B
- Subjects
- Body Fluids, Cyclohexanones, Cyclohexylamines, Drug Overdose, Humans, Ketamine, Immunoassay, Phencyclidine analogs & derivatives, Psychotropic Drugs urine
- Abstract
Methoxetamine (MXE) and the arylcyclohexylamines 3-methoxy-PCP (3-MeO-PCP) and 4-methoxy-PCP (4-MeO-PCP) are substituted analogs of the dissociative psychoactive substances ketamine and phencyclidine (PCP), respectively. They have emerged on the new psychoactive substances (NPS) market as legal alternatives to these classically banned dissociatives. Little data has been published regarding the cross-reactivity of these NPS in PCP immunoassays (IAs). The aim of this work was to explore the possibilities of detecting 3-MeO-PCP, 4-MeO-PCP, MXE and ketamine in commercial IAs for PCP. The cross-reactivity study was performed in five different PCP IAs using urine-free, spiked samples and urine samples obtained from two 3-MeO-PCP overdose cases. 3-MeO-PCP and 4-MeO-PCP showed cross-reactivity (ranging from 1-143%) in all PCP IAs evaluated. MXE only showed very weak cross-reactivity (ranged from 0.04 to 0.25%) and ketamine was not detected in any PCP IA evaluated. Urine samples from the two overdose cases were positive for PCP in all IAs evaluated. The commercial PCP IAs evaluated exhibited utility as rapid, preliminary screening techniques for 3-MeO-PCP and 4-MeO-PCP, but not for ketamine. The low reactivity of MXE limits its detectability in the PCP IAs evaluated., (© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2019
- Full Text
- View/download PDF
16. 2,4-Diamino-N10-methylpteroic acid (DAMPA) crystalluria in a patient with osteosarcoma treated with carboxypeptidase-G2 rescue after high-dose methotrexate-induced nephrotoxicity.
- Author
-
Berga F, Luna P, Martorell C, Rey J, Gomila I, Gimenez S, Costa-Bauza A, Elorza MÁ, Sánchez I, Grases F, and Barceló B
- Subjects
- Adult, Female, Humans, Hydrolysis, Kidney metabolism, Kidney pathology, Methotrexate chemistry, Methotrexate metabolism, Methotrexate therapeutic use, Methotrexate urine, Osteosarcoma drug therapy, Osteosarcoma pathology, Particle Size, Surface Properties, gamma-Glutamyl Hydrolase physiology, Kidney drug effects, Methotrexate adverse effects, Methotrexate analogs & derivatives, Osteosarcoma metabolism, gamma-Glutamyl Hydrolase metabolism
- Abstract
Background: High-dose methotrexate (HDMTX) therapy is a key component of many chemotherapy protocols. However, some patients develop HDMTX-induced nephrotoxicity. Carboxypeptidase-G2 (CPDG2) hydrolyses MTX into 2,4-diamino-N10-methylpteroic acid (DAMPA) and glutamic acid, and is used as a rescue agent in patients with nephrotoxicity and delayed elimination. Despite the frequency of HDMTX-induced renal injury, crystalluria is uncommon. Furthermore, crystals are rarely identified by conventional chemical methods., Objective: To determine the composition of crystalluria in a patient with osteosarcoma who was treated with CPDG2., Methods: Crystalluria was evaluated by optical microscopy, and chemical identification was performed by Fourier-transform infrared (FT-IR) spectroscopy, scanning electron microscopy (SEM) and Orbitrap™ high-resolution mass spectrometry (HRMS)., Results: The HRMS spectra of the patient's urine sediment showed a main peak at m/z 326.13, corresponding to the molecular mass of DAMPA [(C
15 H15 O2 N7 ) + H+ ]. The FT-IR spectral patterns of the sediment and DAMPA were not identical. SEM was unable to identify the crystal., Conclusion: DAMPA crystalluria was identified by Orbitrap™ HRMS in a patient treated with CPDG2 after HDMTX nephrotoxicity. This case reinforces the need to implement adequate measures to prevent nephrotoxicity. In cases of HDMTX-induced nephrotoxicity, urine sediment analysis should be requested., (Copyright © 2018. Published by Elsevier B.V.)- Published
- 2018
- Full Text
- View/download PDF
17. Orbitrap™ high-resolution mass spectrometry for the identification of amoxicillin crystalluria.
- Author
-
Barceló B, Rodriguez A, Ocon Lopez M, Costa-Bauza A, Gomila I, Badal Cogul MB, and Grases F
- Subjects
- Amoxicillin therapeutic use, Anti-Bacterial Agents therapeutic use, Crystallization, Escherichia coli isolation & purification, Humans, Lung Diseases diagnosis, Lung Diseases drug therapy, Lung Diseases microbiology, Male, Mass Spectrometry instrumentation, Microscopy, Middle Aged, Spectroscopy, Fourier Transform Infrared, Tomography, X-Ray Computed, Amoxicillin urine, Anti-Bacterial Agents urine, Mass Spectrometry methods
- Published
- 2018
- Full Text
- View/download PDF
18. Value of glycolic acid analysis in ethylene glycol poisoning: A clinical case report and systematic review of the literature.
- Author
-
Tuero G, González J, Sahuquillo L, Freixa A, Gomila I, Elorza MÁ, and Barceló B
- Subjects
- Biomarkers blood, Biomarkers urine, Gas Chromatography-Mass Spectrometry, Humans, Male, Middle Aged, Poisoning diagnosis, Sensitivity and Specificity, Ethylene Glycol poisoning, Glycolates blood, Glycolates urine
- Abstract
Objective: To evaluate the clinical utility of glycolic acid (GA) determination in the diagnosis and prognosis of ethylene glycol (EG) intoxications., Method: Systematic review of serum and/or urine GA concentrations available in the literature in cases of EG poisoning. Present a clinical case in which the determination of the GA was decisive., Results: In total, 137 patients were included. Serum GA concentrations (but not EG) of patients who survive are different from those who die. The optimal cut-off of serum GA to predict mortality was 990.5mg/L (sensitivity 85.2%, specificity 54.3%) with an Odds Ratio of 6.838 (2.868-16.302). In our clinical case, serum EG was negative; however, urine GA was positive (1230.7mg/L)., Conclusions: In all suspected cases of EG poisoning, it is advisable to carry out the simultaneous analysis of EG and GA., (Copyright © 2018 Elsevier B.V. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
19. The importance of biomarkers of fetal exposure to alcohol and psychotropic drugs in early diagnosis: A case report.
- Author
-
Jarque P, Marchei E, Roca A, Gomila I, Pichini S, Busardò FP, and Barceló B
- Subjects
- Adult, Biomarkers analysis, Early Diagnosis, Female, Humans, Infant, Newborn, Pregnancy, Substance-Related Disorders diagnosis, Fetal Alcohol Spectrum Disorders diagnosis, Prenatal Exposure Delayed Effects diagnosis, Psychotropic Drugs adverse effects
- Published
- 2018
- Full Text
- View/download PDF
20. Quantification of Methamphetamine «Shabu» in Biological Matrices to Detect Prenatal Exposure: A Case Report and a Literature Review.
- Author
-
Jarque P, Roca A, Gomila I, Noce V, Barcelo B, and Klein J
- Subjects
- Adult, Central Nervous System Stimulants analysis, Female, Gas Chromatography-Mass Spectrometry methods, Hair metabolism, Humans, Infant, Newborn, Male, Meconium metabolism, Methamphetamine analysis, Pregnancy, Central Nervous System Stimulants urine, Hair chemistry, Meconium chemistry, Methamphetamine urine, Prenatal Exposure Delayed Effects diagnosis, Prenatal Exposure Delayed Effects urine
- Abstract
Background: Methamphetamine misuse represents an increasing global public health problem. Its consumption during pregnancy becomes a relevant issue, since it has clinical consequences for the child's health and the pregnant woman. Despite this, there are only few data in the literature that include analytical results in the matrices used to detect prenatal exposure., Objectives: 1) Present a case report of prenatal methamphetamine exposure with toxicological analytical confirmation in biological matrices; and 2) Perform a compilation of prenatal methamphetamine exposure studies and case reports which include toxicological analytical results., Methods: Prenatal methamphetamine exposure was confirmed using a traditional "screen with reflex" approach. Methamphetamine and amphetamine were quantified in urine, meconium and hair samples of the neonate and mother by gas chromatography-mass spectrometry. Also, a detailed revision of the existent literature that provides information on the analytical toxicology results has been included., Results: In the neonatal biological matrices test results of methamphetamine/amphetamine were: urine 2,966.43/1,638.71 ng/mL, meconium 1,450/<0.1 ng/g and hair 36.54/9.66 ng/mg. In the maternal biological matrices, test results were: urine 13,393.89/3,074.95 ng/mL and hair 11.29/3.37 ng/mg (0-3 cm), 4.68/2.58 (3-6 cm), 6.43/3.13 ng/mg (6-9 cm) and 4.72/2.49 ng/mg (9-12 cm). These results confirm a recent and continued regular substance use throughout pregnancy including delivery., Conclusion: The data provided will be useful for clinical purposes to improve the diagnostic and follow- up of acute and chronic intoxications. Additionally, results will be used to support interpretations in the field of forensic and legal medicine., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.)
- Published
- 2018
- Full Text
- View/download PDF
21. Building Bridges between Clinical and Forensic Toxicology Laboratories.
- Author
-
Barcelo B, Noce V, and Gomila I
- Subjects
- Death, Sudden, Cardiac epidemiology, Death, Sudden, Cardiac prevention & control, Doping in Sports prevention & control, Humans, Infant, Newborn, Reproducibility of Results, Sudden Infant Death epidemiology, Sudden Infant Death prevention & control, Clinical Laboratory Techniques methods, Clinical Laboratory Techniques standards, Forensic Toxicology methods, Forensic Toxicology standards, Intersectoral Collaboration
- Abstract
Background: Clinical and forensic toxicology can be defined as two disciplines involving the detection, identification and measurement of xenobiotics in biological and non-biological samples to assist in the diagnosis, treatment, prognosis and prevention of poisonings and to disclose causes and contributory causes of fatal intoxications, respectively., Objective: This article explores the close connections between clinical and forensic toxicology in overlapping areas of interest., Methods: An update has been carried out of the following seven areas of interest in analytical toxicology: doping control, Sudden Cardiac Death (SCD), brain death, Sudden Infant Death Syndrome (SIDS) and Munchausen Syndrome by Proxy (MSBP), prenatal exposure to drugs and Fetal Alcohol Syndrome (FAS), Drug-Facilitated Crimes (DFC) and intoxications by new psychoactive substances (NPS)., Results: While issues such as SCD, SIDS or doping control are investigated mainly in forensic laboratories, others such as prenatal exposure to drugs or FAS are mainly treated in clinical laboratories. On the other hand, areas such MSBP, DFC or the intoxications by NPS are of interest in both laboratories. Some of these topics are initially treated in hospital emergency departments, involving clinical laboratories and sometimes lately derived to forensic laboratories. Conversely, cases with initial medicallegal implications and fatalities are directly handled by forensic toxicology, but may trigger further studies in the clinical setting., Conclusion: Many areas of common interest between clinical and forensic laboratories are building bridges between them. The increasing relationships are improving the growth, the reliability and the robustness of both kinds of laboratories., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.)
- Published
- 2018
- Full Text
- View/download PDF
22. Intoxication caused by new psychostimulants: analytical methods to disclose acute and chronic use of benzofurans and ethylphenidate.
- Author
-
Barceló B, Gomila I, Rotolo MC, Marchei E, Kyriakou C, Pichini S, Roset C, Elorza MÁ, and Busardò FP
- Subjects
- Benzofurans adverse effects, Chromatography, High Pressure Liquid, Gas Chromatography-Mass Spectrometry, Humans, Immunoassay, Male, Methylphenidate adverse effects, Methylphenidate analysis, Psychotropic Drugs adverse effects, Tandem Mass Spectrometry, Young Adult, Benzofurans analysis, Hair chemistry, Methylphenidate analogs & derivatives, Psychotropic Drugs analysis, Substance Abuse Detection methods, Substance-Related Disorders diagnosis
- Abstract
The acute and chronic toxicity of several new psychoactive substances (NPS) is unknown, and only little information is available on the pharmacology and toxicology, toxicokinetics, and detectability in body samples of such new compounds. We here propose analytical methods to disclose acute and chronic use of two types of new psychostimulants: benzofurans and ethylphenidate and we applied them to a real case of a subject attending Emergency Department with signs of acute intoxication due to psychotropic drug(s). After a urinary immunoassay screening which gave a positivity to amphetamines, general unknown gas chromatography-mass spectrometry (GC-MS) urine analysis identified 5-(2-methylaminopropyl)benzofuran (5-MAPB), 5-(2-aminopropyl)benzofuran (5-APB), 5-(2-ethylaminopropyl)benzofuran (5-EAPB), ethylphenidate, and ritalinic acid. All these substances were confirmed and quantified not only in urine but also in serum samples at different times after hospitalization by GC-MS and ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS). Two subsequent 2-cm hair segments were also analyzed and tested positive for the above reported substances, evidencing repeated use. The matching quantitative results in all the analyzed biological matrices demonstrated that both analytical methodologies were suitable to correctly quantify NPS involved in the current intoxication. The objective assessment of acute and chronic intoxication by the above reported compounds demonstrate that the development of analytical methods aiming at the detection of a broad spectrum of compounds in conventional and non-conventional biological matrices is helpful when facing the new challenging threat of intoxications caused by NPS.
- Published
- 2017
- Full Text
- View/download PDF
23. Cross-reactivity of selected benzofurans with commercial amphetamine and ecstasy immunoassays in urine.
- Author
-
Gomila I, Moranta C, Quesada L, Pastor Y, Dastis M, Torrents A, Elorza MÁ, Busardò FP, and Barceló B
- Subjects
- Cross Reactions, Gas Chromatography-Mass Spectrometry, Humans, Substance Abuse Detection methods, Amphetamine urine, Benzofurans urine, Immunoassay, N-Methyl-3,4-methylenedioxyamphetamine urine
- Abstract
Aim: The aim of this study was to perform a cross-reactivity investigation of six benzofurans with immunoassays (IAs) screening tests for amphetamines and ecstasy in urine samples., Methods: The following benzofuranes were investigated: 5-(2-Methylaminopropyl)Benzofuran (5-MAPB), 5-(2-methylaminopropyl)-2,3-dihydrobenzofuran (5-MAPDB), 5-(2-Aminopropyl)-Benzofuran (5-APB), 5-(2-Aminopropyl)-2,3-dihydrobenzofuran (5-APDB), 5-(2-Ethylaminopropyl)Benzofuran (5-EAPB) and 5-(2-Aminoethyl)-2,3-dihydrobenzofuran (5-AEDB). The study was performed with urine-free spiked samples and authentic urine samples using eight different IAs for amphetamines and ecstasy. Results: All evaluated benzofurans showed cross-reactivity in some of the IAs tested, except for 5-AEDB. Urine samples of an intoxication case involving 5-MAPB, 5-APB and 5-EAPB were also positives in the IAs tested., Conclusion: There is an important variability in the cross-reactivity of the IAs for amphetamine and ecstasy caused by benzofurans depending on the immunoassay employed and the tested compounds.
- Published
- 2017
- Full Text
- View/download PDF
24. Cross-Reactivity of Pantoprazole with Three Commercial Cannabinoids Immunoassays in Urine.
- Author
-
Gomila I, Barceló B, Rosell A, Avella S, Sahuquillo L, and Dastis M
- Subjects
- False Positive Reactions, Humans, Immunoassay methods, Pantoprazole, Urinalysis, 2-Pyridinylmethylsulfinylbenzimidazoles urine, Cannabinoids urine, Proton Pump Inhibitors urine, Substance Abuse Detection
- Abstract
Pantoprazole is a frequently prescribed proton pump inhibitor (PPI) commonly utilized in the management of gastrointestinal symptoms. Few substances have proved to cause a false-positive cannabinoid urine screen. However, a case of false-positive urine cannabinoid screen in a patient who received a pantoprazole dose has been recently published. The purpose of this study was to determine the potential cross-reactivity of pantoprazole in the cannabinoid immunoassays: Alere Triage® TOX Drug Screen, KIMS® Cannabinoids II and DRI® Cannabinoids Assay. Drug-free urine to which pantoprazole was added up to 12,000 μg/mL produced negative results in the DRI® Cannabinoids and KIMS® Cannabinoids II. Alere Triage® TOX Drug Screen assay gave positive results at pantoprazole concentrations higher than 1,000 μg/mL. Urine samples from 8 pediatric patients were collected at the beginning of their pantoprazole treatment. Alere Triage® TOX Drug Screen assay produced positive test results in all patient samples and KIMS® Cannabinoids II immunoassay produced positive test results in one patient sample. None patient sample gave a false-positive result when analyzed by the DRI® Cannabinoids Assay. Our findings demonstrate that some cannabinoids immunoassays are susceptible to cross-reaction errors resulting from the presence in urine of pantoprazole and the resulting metabolism of the parent drug. Clinicians should be aware of the possibility of false-positive results for cannabinoids after a pantoprazole treatment., (© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2017
- Full Text
- View/download PDF
25. Cross-Reactivity of Chloroquine and Hydroxychloroquine With DRI Amphetamine Immunoassay.
- Author
-
Gomila I, Quesada L, López-Corominas V, Fernández J, Servera MÁ, Sahuquillo L, Dastis M, Torrents A, and Barceló B
- Subjects
- Adolescent, Amphetamine therapeutic use, Antirheumatic Agents urine, Arthritis, Rheumatoid drug therapy, Arthritis, Rheumatoid urine, Chloroquine therapeutic use, Cross Reactions physiology, Female, Humans, Hydroxychloroquine therapeutic use, Immunoassay methods, Substance Abuse Detection methods, Amphetamine urine, Chloroquine urine, Hydroxychloroquine urine
- Abstract
Background: Chloroquine and hydroxychloroquine are medical drugs used to treat the chemoprophylaxis of malaria and a second-line anti-inflammatory drug., Methods: We performed a study of cross-reactivity of chloroquine and hydroxychloroquine in the DRI Amphetamine Assay inspired by a case report of a self-ingestion of chloroquine after a family dispute, that involved the following: (1) an in vitro study with control samples of healthy subjects, (2) an in vivo study with samples of patients with rheumatoid arthritis, and (3) an evaluation of the cross-reactivity of chloroquine and hydroxychloroquine in 3 additional immunoassays., Results: In the case report, the Amphetamine DRI assay resulted positive both at 1000 ng/mL cutoff (1507 and 1137 ng/mL) and at 500 ng/mL cutoff (1178 and 642 ng/mL). Chloroquine urine levels were 103,900 and 100,900 ng/mL at 5 and 9 hours after ingestion. The results with control samples showed a positive cross-reactivity of chloroquine in the DRI Amphetamine Assay (approximately 0.74% and 0.89% at cutoff of 1000 and 500 ng/mL, respectively). Hydroxychloroquine did not cross-react with the DRI Amphetamine Assay up to 1,000,000 ng/mL. In patients treated with chloroquine or hydroxychloroquine, DRI Amphetamine did not produce false-positive results. The comparative assay study showed a positive cross-reactivity of chloroquine in the Emit II Plus Amphetamines Assay with control samples., Conclusions: Chloroquine can cause false-positive results in the DRI Amphetamine Assay when it is present at high concentrations. Hydroxychloroquine did not produce false-positive results neither in the DRI Amphetamine Assay nor in the others immunoassays evaluated.
- Published
- 2017
- Full Text
- View/download PDF
26. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series.
- Author
-
Barceló B, Pichini S, López-Corominas V, Gomila I, Yates C, Busardò FP, and Pellegrini M
- Subjects
- Adolescent, Akathisia, Drug-Induced, Anxiety chemically induced, Confusion chemically induced, Female, Headache chemically induced, Humans, Male, Mydriasis chemically induced, Psychoses, Substance-Induced, Vomiting chemically induced, Young Adult, Cannabinoids adverse effects, Designer Drugs adverse effects, Substance-Related Disorders complications
- Abstract
Synthetic cannabinoids are relatively new substances of abuse. Recently, abuse of synthetic cannabinoids has been increasingly reported in the lay press and medical literature. When new compounds are introduced, their use is initially not restricted by prohibition therefore their consumption cannot be verified by standard drug tests. The use of these compounds among adolescents and young adults is constantly growing, making it important for emergency services to be familiar with the signs and symptoms of intoxication present. Overdose and chronic use of these substances can cause adverse effects including altered mental status, tachycardia, and loss of consciousness. Here, we report five cases of acute intoxication by synthetic cannabinoids 5F-ADB and MMB-2201 with analytical confirmation., (Copyright © 2017 Elsevier B.V. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
27. Pharmacology and Literature Review Based on Related Death and Non-Fatal Case Reports of the Benzofurans and Benzodifurans Designer Drugs.
- Author
-
Barcelo B and Gomila I
- Subjects
- Adult, Benzofurans analysis, Benzofurans chemistry, Designer Drugs analysis, Designer Drugs chemistry, Fatal Outcome, Hallucinogens analysis, Hallucinogens chemistry, Humans, Illicit Drugs analysis, Illicit Drugs chemistry, Male, Young Adult, Benzofurans adverse effects, Designer Drugs adverse effects, Hallucinogens adverse effects, Illicit Drugs adverse effects, Substance Abuse Detection methods
- Abstract
Background: Benzofurans and benzodifurans are two groups of psychoactive substances that had originally been synthesized for research purpose. Benzofurans' structure is quite similar to the known recreational drug 3,4-methylenedioxymethamphetamine together with its active metabolite 3,4-methylenedioxyamphetamine. Benzodifurans are closely related to phenethylamines, but have more hallucinogens effects and much longer duration of action. This study aims to review the accessible evidence-based literature on benzofurans and benzodifurans pharmacology and toxicology., Methods: A literature search on benzofurans and benzodifurans has been conducted using PubMed. We reviewed articles up to February 2017 and also included data from various governmental websites and discussion groups., Results: This review describes the emergent literature that illustrates the chemical composition of these drugs, patterns of use, pharmacology, toxicology, desired and clinical effects, and treatments of patients. It also provides a compilation of case reports., Conclusion: The knowledge regarding usage prevalence, pharmacokinetic and pharmacodynamic profiles, acute toxic effects, the effects desired on patients and drug related mortality attributed to these drugs is still limited. Nowadays, there are no specific guidelines available to treat benzofurans or dibenzofurans intoxications. For that reason, clinical effects should be the base of treatment. Backing exposures analytically confirmed in clinical and forensic cases and reported clinical effects need to be combined with these compounds while monitoring its prevalence., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.)
- Published
- 2017
- Full Text
- View/download PDF
28. Alimemazine poisoning as evidence of Munchausen syndrome by proxy: A pediatric case report.
- Author
-
Gomila I, López-Corominas V, Pellegrini M, Quesada L, Miravet E, Pichini S, and Barceló B
- Subjects
- Antipruritics analysis, Child Abuse diagnosis, Child, Preschool, Chromatography, Liquid, Gas Chromatography-Mass Spectrometry, Gastrointestinal Contents chemistry, Hair chemistry, Humans, Male, Trimeprazine analysis, Antipruritics poisoning, Munchausen Syndrome by Proxy diagnosis, Trimeprazine poisoning
- Abstract
Munchausen syndrome by proxy (MSBP), also known as fabricated or induced illness in a child by a caretaker, is a form of abuse where a caregiver deliberately produces or feigns illness in a person under his or her care, so that the proxy will receive medical care that gratifies the caregiver. The affected children are often hospitalized for long periods and endure repetitive, painful and expensive diagnostic attempts. We present an analytically confirmed case of MSBP by alimemazine. A 3-year-old boy was brought repetitively to a Pediatric Emergency Department by his mother because he presented limb tremors, dysarthria, obnubilation, and ataxia and generalized tonic-clonic seizures coinciding with intermittent fever. Neither the rest of the physical examination nor the complementary tests showed any significant alterations. MSBP was suspected and a routine systematic toxicological analysis in urine and blood was requested. Alimemazine was detected in all biological samples. The administration of this drug was never mentioned by the mother and the subsequent interview with her corroborated the suspicion of MSBP. Clinically, after separation from the mother, the child's neurological symptoms gradually improved until the complete disappearance of the cerebellar symptoms. Alimemazine was quantified in serum, urine, gastric content and cerebrospinal fluid samples by gas chromatography-mass spectrometry (maximum serum level was 0.42μg/ml). Hair quantification of alimemazine was performed by ultra-performance liquid chromatography-tandem mass spectrometry in different segments of hair. The results confirmed regular substance use during the at least eight last months (8.8, 14.7, 19.7 and 4.6ng/mg hair starting from most proximal segment). This patient represents the first case published with analytical data of alimemazine in blood, urine, gastric content, cerebrospinal fluid and hair, which allowed us to prove an acute and repetitive poisoning with alimemazine as evidence of MSBP., (Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
29. Elimination half-life of alpha-pyrrolidinovalerophenone in an acute non-fatal intoxication.
- Author
-
Quesada L, Gomila I, Yates C, Barcelo C, Puiguriguer J, and Barcelo B
- Subjects
- Acute Disease, Administration, Intravenous, Central Nervous System Stimulants pharmacokinetics, Dose-Response Relationship, Drug, Half-Life, Humans, Male, Midazolam therapeutic use, Pyrrolidines pharmacokinetics, Tachycardia chemically induced, Tachycardia drug therapy, Young Adult, Central Nervous System Stimulants toxicity, Psychoses, Substance-Induced drug therapy, Pyrrolidines toxicity
- Published
- 2016
- Full Text
- View/download PDF
30. Fenofibric Acid Can Cause False-Positive Urine Methylenedioxymethamphetamine Immunoassay Results.
- Author
-
Quesada L, Gomila I, Fe A, Servera MA, Yates C, Morell-Garcia D, Castanyer B, and Barceló B
- Subjects
- False Positive Reactions, Female, Fenofibrate urine, Gas Chromatography-Mass Spectrometry, Glucuronidase metabolism, Humans, Substance Abuse Detection, Young Adult, Fenofibrate analogs & derivatives, Immunoassay, N-Methyl-3,4-methylenedioxyamphetamine urine
- Abstract
We present a false-positive result of ecstasy (3,4-methylenedioxy-NN-methylamphetamine) screening due to the therapeutic use of fenofibrate, an antihyperlipidemic drug. Our hypothesis was that the main metabolite of fenofibrate, fenofibric acid, was responsible for this cross-reactivity on a DRI(®) Ecstasy Assay, using a cut-off of 500 ng/mL. We estimated that the addition of 225 µg/mL pure fenofibric acid to blank urine would be sufficient to result in a positive DRI(®) Ecstasy Assay. The results obtained on the urine samples analyses of the patient show that the DRI(®) Ecstasy Assay resulted negative 2 days after discontinuing fenofibrate treatment, when the urine fenofibric acid concentration corrected by creatinine and determinated by gas chromatography-mass spectrometry was 20.3 µg/mg creatinine. The cross-reactivity data for fenofibric acid would seem to indicate that there was insufficient concentration of measured compound to account for the positive immunochemical results for ecstasy. This apparent discrepancy can be explained in several ways, one of them is that the β-glucuronidase-resistent fenofibric acid isomers are responsible. This process could explain the low recovery of free fenofibric acid when we use the developed method for its quantification in urine samples. Positive results on immunoassay screening must be considered presumptive until confirmation with another method based on a different principle, preferably gas chromatography-mass spectrometry or liquid chromatography-mass spectrometry., (© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.